Drug Trial Radar · NCT05762107
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Last checked: Nov 19, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
186
Planned (sponsor's estimate)
Start
Jul 28, 2023
Primary completion
Dec 2026
Study completion May 2027
Sponsor
- Lead sponsor
- Zucara Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 9, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having low blood sugars ("hypos") at night. ZT-01 increases the amount of a hormone called glucagon during low blood sugar, and this may help prevent the occurrence of hypos. The main questions this trial aims to answer are whether ZT-01 lowers the number of hypos happening at night, and what its effects are on blood sugar levels. The safety of ZT-01 will also be measured. Participants will be asked to wear a study-provided continuous glucose monitor (CGM) during two 4-week periods when they will self-inject the study drug before bed. They will get ZT-01 at one of three dose levels during one period, and placebo (which looks like the study drug but doesn't contain the active ingredient) during the other. Neither the participant nor the study site will know what they are receiving during each treatment period or see data from the CGM. The participant will continue to use their usual methods of measuring blood sugar (including their personal CGM) and giving insulin during the study. The participant will be asked to complete a short diary each evening, and will be asked to upload the CGM data to a study phone every day. If a participant uses their own CGM and is willing to share information on how often they have low blood sugar with the study site at the first visit to see if they meet study entry requirements, they will have 6 study visits, 2 study phone calls, and be in the study for about 16 weeks. If they don't use CGM or don't want to share their information, then they will be asked to wear a study CGM for an extra 4 weeks to find out how many low blood sugars they have, and will have an extra visit. Study participants will be asked to give blood and urine for testing to see whether they meet the requirements to enter the study, and at the start and end of each treatment period to see if the study treatment has any effects. They will also have their blood pressure and temperature taken at each study visit, and have an ECG at 4 visits to measure the electrical activity of their heart. Some participants will be asked to also take part in a sub-study where their blood level of ZT-01 and glucagon is measured, after the first and last dose. They will be asked to stay at the study site overnight for each set of measurements (4 in total).
Conditions
- Type 1 Diabetes Mellitus With Hypoglycemia
Interventions
PlaceboDrug
Subject receives Placebo by subcutaneous injection daily for 28 days
ZT-01, 7 mgDrug
Subject receives ZT-01 7 mg by subcutaneous injection daily for 28 days
ZT-01, 15 mgDrug
Subject receives ZT-01 15 mg by subcutaneous injection daily for 28 days
ZT-01, 22 mgDrug
Subject receives ZT-01 22 mg by subcutaneous injection daily for 28 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of nocturnal hypoglycemiaTime frame: During each 28 day treatment period
Locations
46 sites in 2 countries. Site status is shown where the registry gives one.
Kirklin Clinic of UAB Hospital-Endocrinology/Diabetes Clinic
Birmingham, Alabama · Recruiting
Medical Investigations Indications Inc.
Little Rock, Arkansas · Recruiting
Headlands Research
Escondido, California · Recruiting
USC Keck Medicine Eastside Center for Diabetes
Los Angeles, California · Recruiting
LCGK Research
San Carlos, California · Terminated
Barbara Davis Center for Diabetes
Aurora, Colorado · Recruiting
Yale University - Diabetes Research Office
New Haven, Connecticut · Recruiting
East Coast Institute for Research LLC
Jacksonville, Florida · Recruiting
Suncoast Clinical Research
New Port Richey, Florida · Recruiting
Hanson Diabetes Center
Port Charlotte, Florida · Recruiting
University of South Florida Diabetes & Endocrinology Clinic
Tampa, Florida · Recruiting
Metabolic Research Institute
West Palm Beach, Florida · Recruiting
Atlanta Diabetes Associates
Atlanta, Georgia · Recruiting
Physicians Research Associates LLC
Lawrenceville, Georgia · Recruiting
East Coast Institute for Research
Macon, Georgia · Recruiting
University of Chicago Medical Center
Chicago, Illinois · Recruiting
IU Health University Hospital
Indianapolis, Indiana · Recruiting
University of Kansas Medical Center
Kansas City, Kansas · Recruiting
Ochsner Clinic Foundation
New Orleans, Louisiana · Recruiting
Baltimore VA Medical Center
Baltimore, Maryland · Recruiting
MedStar Good Samaritan Hospital
Baltimore, Maryland · Recruiting
Elite Research Center
Flint, Michigan · Recruiting
University of Nebraska Medical Center
Omaha, Nebraska · Recruiting
Palm Research Center, Inc.
Las Vegas, Nevada · Recruiting
Albany Medical Center
Albany, New York · Recruiting
NYC Research Inc.
Long Island City, New York · Recruiting
NYU Langone Health CTSI
New York, New York · Recruiting
Lucas Research Inc.
Morehead City, North Carolina · Recruiting
Ohio State University Wexner Medical Center
Columbia, Ohio · Recruiting
Thomas Jefferson University
Philadelphia, Pennsylvania · Recruiting
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania · Recruiting
University Diabetes & Endocrine Consultants
Chattanooga, Tennessee · Recruiting
Texas Diabetes & Endocrinology, PA
Austin, Texas · Recruiting
North Texas Endocrine Center
Dallas, Texas · Recruiting
Southern Endocrinology Associates
Mesquite, Texas · Recruiting
Diabetes & Glandular Disease Clinic
San Antonio, Texas · Recruiting
Diabetes & Endocrine Treatment Specialists
Sandy City, Utah · Recruiting
University of Washington Diabetes Institute - Clinical Research Unit
Seattle, Washington · Recruiting
Centricity Research Calgary Endocrinology
Calgary, Alberta, Canada · Recruiting
Richmond Road Diagnostic & Treatment Centre, Clinical Trials Unit
Calgary, Alberta, Canada · Recruiting
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.